BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6297102)

  • 1. [Changes in the hypothalamo-hypophyseal-adrenal (HHA) system in chronic alcohol abuse].
    Nickel B; Koalick F; Kemper A; Müller R
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():169-78. PubMed ID: 6297102
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status of knowledge on the changes in the hypothalamo-hypophyseo-adrenal cortex system and their effects in chronic alcohol use and withdrawal].
    Nickel B; Kemper A
    Psychiatr Neurol Med Psychol (Leipz); 1982 Aug; 34(8):449-59. PubMed ID: 6292975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response of the hypothalamo-hypophyseal-adrenal system to insulin].
    Narbaev BN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Oct; 69(10):1361-4. PubMed ID: 6315496
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis.
    Rasmussen DD; Boldt BM; Bryant CA; Mitton DR; Larsen SA; Wilkinson CW
    Alcohol Clin Exp Res; 2000 Dec; 24(12):1836-49. PubMed ID: 11141043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of corticotrophin on hypothalmic-pituitary-adrenal function of children.
    Friedman M
    Proc R Soc Med; 1968 Mar; 61(3):291-3. PubMed ID: 4297157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of the hypothalamic-hypophyseal-adrenal cortex regulatory zone with ACTH and the metopirone test in long-term glucocorticoid therapy].
    Saitmacher F
    Dtsch Gesundheitsw; 1970 Dec; 25(49):2334-8. PubMed ID: 4324036
    [No Abstract]   [Full Text] [Related]  

  • 7. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
    Vollenweider P; Waeber G
    Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis.
    Jasani MK; Boyle JA; Greig WR; Dalakos TG; Browning MC; Thompson A; Buchanan WW
    Q J Med; 1967 Jul; 36(143):261-76. PubMed ID: 6049762
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the problem of the functional status of the hypothalamo-hypophyseal-adrenal system in vibration-induced pathology].
    Dumkin VN
    Gig Tr Prof Zabol; 1966 Jun; 10(6):14-8. PubMed ID: 4294380
    [No Abstract]   [Full Text] [Related]  

  • 10. The hypothalamus-pituitary-adrenal axis in HIV disease.
    Freda PU; Bilezikian JP
    AIDS Read; 1999; 9(1):43-50. PubMed ID: 12728883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotrophic-hormone deficiency in chronic myelogenous leukemia after treatment.
    Tobin MS; Kyung-Suk-Kim ; Kossowsky WA
    N Engl J Med; 1970 Jan; 282(4):187-90. PubMed ID: 4311881
    [No Abstract]   [Full Text] [Related]  

  • 12. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
    Farren CK; O'Malley S; Grebski G; Maniar S; Porter M; Kreek MJ
    Alcohol Clin Exp Res; 1999 Mar; 23(3):502-8. PubMed ID: 10195825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of propranolol on the function of the hypothalamo-pituitary-adrenal system in normal and obese subjects during insulin test of hypoglycemia].
    Balestreri R; Bertolini S; Elicio N
    Arch Maragliano Patol Clin; 1973 Jan; 29(1):15-35. PubMed ID: 4801929
    [No Abstract]   [Full Text] [Related]  

  • 14. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
    Hundt W; Zimmermann U; Pöttig M; Spring K; Holsboer F
    Alcohol Clin Exp Res; 2001 May; 25(5):687-91. PubMed ID: 11371718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients.
    Targum SD; Wheadon DE; Chastek CT; McCabe WJ; Advani MT
    J Affect Disord; 1982 Dec; 4(4):347-53. PubMed ID: 6219148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypothalamo-anterior pituitary-adrenal cortex system under continuous alternating and circadian fluocortolone therapy following kidney transplantation].
    von der Nahmer D; Siedek M; Malchau V
    Med Klin; 1972 Dec; 67(51):1700-5. PubMed ID: 4349665
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal cortisol response to corticotropin in patients with secondary adrenal failure.
    Cunningham SK; Moore A; McKenna TJ
    Arch Intern Med; 1983 Dec; 143(12):2276-9. PubMed ID: 6316866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypocorticism of therapeutic origin. 3. Current survey of ACTH-therapy].
    Coste F; Massias P
    Sem Hop; 1970 Feb; 46(9):604-15. PubMed ID: 4314356
    [No Abstract]   [Full Text] [Related]  

  • 19. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropic hormone/cortisol response to physical exercise in abstinent alcoholic patients.
    Coiro V; Casti A; Jotti GS; Rubino P; Manfredi G; Maffei ML; Melani A; Volta E; Chiodera P
    Alcohol Clin Exp Res; 2007 May; 31(5):901-6. PubMed ID: 17386066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.